IQVIA SOLUTIONS ASIA PTE. LTD.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Computer Processing and Data Preparation and Processing Services, Information Retrieval Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about IQVIA SOLUTIONS ASIA PTE. LTD.
Live alerts from global media, monitored by Business Radar
2025-04-23 (biospace.com)
SCIENTURE announces manufacturing and supply chain readiness for ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025. -
TAMPA, FL, April 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, is pleased to announce the initiation of supply chain activities by its wholly owned subsidiary Scienture, LLC to manufacture launch quantities of ArbliTM (losartan potassium) Oral Suspension, 10 mg/mL for the intended commercial launch of the product in July 2025. Scirenture, LLC's contract manufacturing partner, Saptalis Pharmaceuticals, LLC for ArbliTM has indicated to Scienture that Saptalis has the materials and capabilities to produce the batches and supply product inventory in time for the target commercial launch.
Read more
2024-08-08 (op-marburg.de)
AI in Marburg: Digital Minister Sinemus gains insights into strictly secured laboratories
Hesse's Digital Minister Kristina Sinemus demands during a company visit to Marburg: "We want and must use and promote the potential of AI in the health sector."
Read more
2024-06-09 (medicinasa.com.br)
90% of Brazilians prefer the production of medicines and inputs in the country
A study carried out by IQVIA Consumer Health shows that the public prefers the production of pharmaceutical inputs and drugs on national soil.
Read more
(biospectrumasia.com)
Next-Gen ADCs as Precision Weapon Against Cancer
Next-Gen ADCs as Precision Weapon Against Cancer
Read more